Editorial: (Thematic Issue: Autoimmune diseases: What have we learned from mice?)

E-ISSN： 1873-4286|21|18|2306-2307

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.18, 2015-06, pp. : 2306-2307

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Biologics in Autoimmune Diseases)

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 6, 2014-01 ,pp. : 509-509

Bentham Science Publishers

Access to resources Recommend Favorite

Myc - What We have Learned from Flies

Current Drug Targets, Vol. 10, Iss. 7, 2009-07 ,pp. : 590-601

Bentham Science Publishers

Access to resources Recommend Favorite

CCR1 Antagonists: What Have We Learned From Clinical Trials

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 13, 2010-09 ,pp. : 1268-1277

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Therapies Targeting Oxidative Stress for Human Diseases: Where Are We Now?)

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 3, 2015-03 ,pp. : 195-195

Bentham Science Publishers

Access to resources Recommend Favorite

Dictyostelium genomics: how it developed and what we have learned from it

By Noegel A. A. Glöckner G.

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 7, 2013-07 ,pp. : 474-477

Govi-Verlag

Access to resources Recommend Favorite